Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Definitive separation of graft-versus-leukemia- and graft-versus-host-specific CD4 <sup>+</sup> T cells by virtue of their receptor β loci sequences

16 Jan 2003

Abstract excerpt

Although graft-versus-host (GVH) disease (GVHD) is usually associated with graft versus leukemia (GVL), GVL can occur in the absence of clinical GVHD. There is evidence to suggest that GVL and GVH are mediated by different clones of T cells. The objective of this study was to identify the two types of T cells based on their receptor sequences. To this end we used irradiated nonleukemic cells from recipients as...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Hematopoietic Stem Cell Transplantation
Share to Immune Cell Function and Interaction
Share to T-cell and B-cell Immunology

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 12531922
DOI: 10.1073/pnas.0337543100

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Definitive separation of graft-versus-leukemia- and graft-versus-host-specific CD4 <sup>+</sup> T cells by virtue of their receptor β loci sequencesPMID 12531922Read ↗

Prevention of graft-versus-host disease (GVHD) by elimination of recipient-reactive donor T cells with recombinant toxins that target the interleukin 2 (IL-2) receptor.Semantic proximity Read ↗

Tissue-restricted T cell alloresponses across HLA barriers: selection and identification of leukemia-restricted CTL in HLA-mismatched stimulator-responder pairs.Semantic proximity Read ↗

Characterization of effector cells of graft vs leukemia following allogeneic bone marrow transplantation in mice inoculated with murine B-cell leukemia.Semantic proximity Read ↗

Dissecting graft‐versus‐leukemia from graft‐versus‐host‐disease using novel strategiesSemantic proximity Read ↗

Effective depletion of alloreactive lymphocytes from peripheral blood mononuclear cell preparations.Semantic proximity Read ↗

Analysis of T-cell receptor variability in transplanted patients with acute graft-versus-host disease.Semantic proximity Read ↗

Critical role for CCR5 in the function of donor CD4+CD25+ regulatory T cells during acute graft-versus-host disease.Semantic proximity Read ↗

Functional and phenotypic differences between CD4+ and CD4- T cell receptor-gamma delta clones from peripheral blood.Semantic proximity Read ↗

CD25+ immunoregulatory T-cells of donor origin suppress alloreactivity after BMTSemantic proximity Read ↗

Post-hematopoietic cell transplantation control of graft-versus-host disease by donor CD4+25+ T cells to allow an effective graft-versus-leukemia responseSemantic proximity Read ↗

CD25 expression on donor CD4+ or CD8+ T cells is associated with an increased risk for graft-versus-host disease after HLA-identical stem cell transplantation in humansSemantic proximity Read ↗

Prevention of GVHD while sparing GVL effect by targeting Th1 and Th17 transcription factor T-bet and RORγt in miceSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.